Canada's low-cost base and regulatory environment provides development companies with a flying start
This article was originally published in Clinica
With research and development costs up to 50% cheaper than in the US and a regulatory environment which can cut a year off time to market, Canada offers medical technology manufacturers many benefits. Liz Hicks reports on four of Canada's thriving companies which shared their success stories at the Canadian industry association MEDEC's Spring Business Conference in Toronto this month.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.